AT-201 (A28 Therapeutics)

N/A

Report date: 2025/05/26 10:52:17
NME

Base Information

Drug NameAT-201 (A28 Therapeutics)
Drug Alias NameAT-201
ClassificationOther
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor modulators
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA28 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesA28 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A